Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03215836 · ClinicalTrials.gov registry record · NA

Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

A NA study of Obesity and Asthma, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03215836 is a NA study of Obesity and Asthma that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 50 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03215836, a NA study of Obesity and Asthma, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The objective of this pilot study is to determine whether obesity and metabolic syndrome are in fact synergistic in relation to airway nitric oxide (NO) biology. To do so, the investigators want to determine how obesity and the metabolic syndrome relate to metabolism in bronchial airway epithelial cells and the nasal epithelium.

Interventions

  • PROCEDURE Bronchoscopy and Nasal Epithelium Brush Sampling

Study Locations (1)

Colorado

  • University of Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-08-10
Est. Completion 2029-12-31
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT03215836

The ClinicalTrials.gov registry entry for NCT03215836 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (94% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Bronchoscopy and Nasal Epithelium Brush Sampling is the first listed.

NCT03215836 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT03215836 about?

NCT03215836 is a clinical study titled "Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics". The objective of this pilot study is to determine whether obesity and metabolic syndrome are in fact synergistic in relation to airway nitric oxide (NO) biology. To do so, the investigators want to determine how obesity and the metabolic syndrome relate to metabolism in bronchial airway epithelial c...

What is the current status of trial NCT03215836?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2017-08-10. Estimated completion is 2029-12-31.

What conditions does trial NCT03215836 study?

This clinical trial studies the following conditions: Obesity, Asthma, Metabolic Syndrome.

What interventions are being tested in trial NCT03215836?

The interventions under investigation include: Bronchoscopy and Nasal Epithelium Brush Sampling (PROCEDURE).

Who is sponsoring clinical trial NCT03215836?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03215836 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.